Total Funding
82
66
Total FundingDebt Financing raised
Growth Score
-10 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
65089
Ocular Science is a biotech company reducing dry eye and inflammation through post-operative care.
- Anthony Sampietro: Co-Founder and CEO
- Damien Goldberg: Co-Founder and Chief Medical Officer
About the Company
Ocular Sciences is a biotech company reducing dry eye and inflammation through post-operative care and provides cost-effective, efficacious products to physicians and their patients for surgical vision correction, myopia control. and the management of glaucoma and dry eye disease. The company focuses on the production of paradigm-shifting
ophthalmic products that are easy to use, cost-effective, and promote patient compliance.
Founded in 2015, Ocular Science is headquartered in Manhattan Beach, California.
